CXCL9 and hepatocellular carcinoma: To further validate the immunostimulatory role of the CXCL9+ TAMs, we analyzed a scRNA-seq dataset of HCC patients receiving immunotherapy with differential response outcomes (Supplementary Figures 3F–I).